Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain cancer patients get extended access to experimental combo therapy in new study

NCT ID NCT07569042

First seen May 07, 2026 · Last updated May 17, 2026 · Updated 3 times

Summary

This study offers continued treatment with NBM-BMX and temozolomide to 15 adults with newly diagnosed glioblastoma who finished a prior study. Researchers will monitor side effects and track how long patients live without the cancer worsening. The goal is to see if the combination is safe and helps control the disease over time.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT NEOPLASM OF BRAIN are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Kaohsiung Medical University Chung-Ho Memorial Hospital

    NOT_YET_RECRUITING

    Kaohsiung City, 807, Taiwan

    Contact Phone: •••-•••-••••

  • Linkou Chang-Gung Memorial Hospital

    RECRUITING

    Taoyuan City, 333, Taiwan

    Contact Phone: •••-•••-••••

  • Taichung Veterans General Hospital

    NOT_YET_RECRUITING

    Taichung, 407, Taiwan

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.